Javascript must be enabled to continue!
FORMULATION AND EVALUATION OF BILAYERED FELODIPINE TRANSDERMAL PATCHES: IN VITRO AND EX VIVO CHARACTERIZATION
View through CrossRef
Objective: Felodipine (FD) is an effective Biopharmaceutics Classification System Class II calcium channel blocker mainly used in the management of hypertension and angina pectoris. It has poor solubility and low oral bioavailability (15%). To overcome these disadvantages and to maintain constant plasma concentration for maximum therapeutic activity, there is a need to design an alternative route, that is, transdermal route. The pharmacokinetic parameters make FD a suitable candidate for transdermal delivery. The present investigation consists of the study of in vitro and ex vivo skin flux of FD from bilayered transdermal patches.
Methods: The patches were fabricated by solvent casting method using hydrophilic and hydrophobic polymer with different composition. Tween 80 incorporated as solubilizer, polyethylene glycol 600 as plasticizer, menthol, eucalyptus oil, and lemongrass oil used as permeation enhancers, respectively. The prepared transdermal drug delivery system was extensively evaluated for in vitro release, ex vivo permeation through pig ear skin, moisture content, moisture absorption, water vapor transmission, and mechanical properties. The physicochemical interaction between FD and polymers was investigated by Fourier-transform infrared (FTIR) spectroscopy.
Results: All the formulations exhibited satisfactory physicochemical and mechanical characteristics. A flux of 35.2 μg/cm2 h, 27.9 μg/cm2 h, and 25.25 μg/cm2 h was achieved for optimized formulations containing lemongrass oil, eucalyptus oil, and menthol, respectively, permeation enhances. Values of tensile strength (0.0652±0.034 kg/mm²) and elongation at break (0.8749±0.0.0029% mm²) revealed that formulation F9 was strong but not brittle. Drug and excipients compatibility studies showed no evidence of interaction between the active ingredient and polymers.
Conclusion: Bilayered FD transdermal patches could be prepared with required flux and suitable mechanical properties.
Innovare Academic Sciences Pvt Ltd
Title: FORMULATION AND EVALUATION OF BILAYERED FELODIPINE TRANSDERMAL PATCHES: IN VITRO AND EX VIVO CHARACTERIZATION
Description:
Objective: Felodipine (FD) is an effective Biopharmaceutics Classification System Class II calcium channel blocker mainly used in the management of hypertension and angina pectoris.
It has poor solubility and low oral bioavailability (15%).
To overcome these disadvantages and to maintain constant plasma concentration for maximum therapeutic activity, there is a need to design an alternative route, that is, transdermal route.
The pharmacokinetic parameters make FD a suitable candidate for transdermal delivery.
The present investigation consists of the study of in vitro and ex vivo skin flux of FD from bilayered transdermal patches.
Methods: The patches were fabricated by solvent casting method using hydrophilic and hydrophobic polymer with different composition.
Tween 80 incorporated as solubilizer, polyethylene glycol 600 as plasticizer, menthol, eucalyptus oil, and lemongrass oil used as permeation enhancers, respectively.
The prepared transdermal drug delivery system was extensively evaluated for in vitro release, ex vivo permeation through pig ear skin, moisture content, moisture absorption, water vapor transmission, and mechanical properties.
The physicochemical interaction between FD and polymers was investigated by Fourier-transform infrared (FTIR) spectroscopy.
Results: All the formulations exhibited satisfactory physicochemical and mechanical characteristics.
A flux of 35.
2 μg/cm2 h, 27.
9 μg/cm2 h, and 25.
25 μg/cm2 h was achieved for optimized formulations containing lemongrass oil, eucalyptus oil, and menthol, respectively, permeation enhances.
Values of tensile strength (0.
0652±0.
034 kg/mm²) and elongation at break (0.
8749±0.
0029% mm²) revealed that formulation F9 was strong but not brittle.
Drug and excipients compatibility studies showed no evidence of interaction between the active ingredient and polymers.
Conclusion: Bilayered FD transdermal patches could be prepared with required flux and suitable mechanical properties.
Related Results
Formulation, Development and Characterization of Transdermal Patches of Metformine Hydrochloride as Lοw Dοse Maintenance Therapy
Formulation, Development and Characterization of Transdermal Patches of Metformine Hydrochloride as Lοw Dοse Maintenance Therapy
The οbjective οf the prοpοsed study was tο develοp lοw dοse support treatment οf metformin hydrochloride in diabetic patients. The pοtassium brοmide pellet was mοunted in IR compar...
FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF PSEUDOEPHEDRINE HCL
FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF PSEUDOEPHEDRINE HCL
Objective: This study was conducted to design a transdermal dosage form of pseudoephedrine HCL and to evaluate its release under controlled rates for sustained transdermal delivery...
Formulation and Evaluation of Herbal Transdermal Patches using Abutilon indicum linn for Rheumatoid Arthritis
Formulation and Evaluation of Herbal Transdermal Patches using Abutilon indicum linn for Rheumatoid Arthritis
Transdermal drug delivery systems (TDDS) offer a
promising alternative for the controlled and noninvasive delivery of drugs. This study explores the
development and evaluation of h...
STICK TO IT: A COMPREHENSIVE REVIEW OF TRANSDERMAL PATCH TECHNOLOGY
STICK TO IT: A COMPREHENSIVE REVIEW OF TRANSDERMAL PATCH TECHNOLOGY
An innovative way to medication distribution, transdermal patches provide a regulated, non-invasive, and patient-friendly substitute for conventional techniques. Transdermal patch ...
Formulation development and characterization of Lecarnidipine hydrochloride niosomal transdermal patches
Formulation development and characterization of Lecarnidipine hydrochloride niosomal transdermal patches
The bioavailability of Lercanidipine Hydrochloride (LCP) is about 44% and half-life of the drug is about 4.6 hours. LCP due to its low therapeutic dose range of 2.5 to 20mg and sub...
Predicting grey‐sided vole occurrence in northern Sweden at multiple spatial scales
Predicting grey‐sided vole occurrence in northern Sweden at multiple spatial scales
AbstractForestry is continually changing the habitats for many forest‐dwelling species around the world. The grey‐sided vole (Myodes rufocanus) has declined since the 1970s in fore...
Current Technological Trends in Transdermal Biosensing
Current Technological Trends in Transdermal Biosensing
Transdermal biosensing focuses on the qualitative and quantitative collection and detection of biomarkers on and in the skin layers. In comparison to the blood‐based diagnosis, tra...
FORMULATION AND EVALUATION OF PHYSOSTIGMINE-TRANSDERMAL PATCH
FORMULATION AND EVALUATION OF PHYSOSTIGMINE-TRANSDERMAL PATCH
In present study transdermal drug delivery of Physostigmine was developed to overcome the first pass metabolism and to reduce frequency of dosing compared to oral route. Matrix typ...

